[1]Herrmann RP，Sturm MJ.Adult human mesenchymal stromal cells and the treatment of graft versus host disease.Stem Cells and Cloning，2014，7：45-52.

[2]Caplan AI，Correa D.The MSC：an injury drugstore.Cell Stem Cell，2011，9(1)：11-15.

[3]Parekkadan B，Milwid JM.Mesenchymal Stem Cells as Therapeutics.Annu Rev Biomed Eng，2010，12：87-117.

[4]Le Blanc K，Rasmusson I，Sundberg B，etal.Treatment of severe acute graft-versus-host diseasewith third party haploidenticalmesenchymal stem cells.Lancet，2004，363(9419)：1439-1441.

[5]Kebriaei P，Isola L，Bahceci E，et al.Adult humanmesenchymal stem cells added to corticosteroid therapy for the treatment of acute graft-versus-host disease.Biol Blood Marrow Transplant，2009，15(7)：804-811.

[6]Kurtzberg J，Prockop S，Teira P，etal.Allogeneic humanmesenchymal stem cell therapy(remestemcel-L，Prochymal)as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients.Biol Blood Marrow Transplant，2014，20(2)：229-235.

[7]Le Blanc K，Frassoni F，Ball L，et al.Mesenchymal stem cells for treatment of steroid-resistant，severe，acute graft-versus-host disease：a phase II study.Lancet，2008，371(9624)：1579-1586.

[8]Prasad VK，Lucas KG，Kleiner GI，et al.Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells(Prochymal ^TM)in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study.Biology of Blood and Marrow Transplantation，2011，17(4)：534-541.

[9]Ringdén O，Uzunel M，Rasmusson I，et al.Mesenchymal stem cells for treatment of therapy-resistant graftversus-host disease.Transplantation，2006，81(10)：1390-1397.

[10]Von Bonin M，Stölzel F，Goedecke A，etal.Treatmentof refractory acute GVHD with third-party MSC expanded in platelet lysate-containingmedium.Bone Marrow Transplant，2009，43(3)：245-251.